Search results for: 'Single cell analysis lasers'

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

This study provides an in-depth examination of recent advancements in next-generation terahertz (THz) imaging and sensing technologies and their increasingly transformative impact across healthcare diagnostics and security-related applications. It focuses on how emerging THz systems, enabled by significant progress in quantum cascade lasers (QCLs),...

This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

This research benchmarks the leading companies in the emerging heavy-lift cargo drone industry based on two criteria: growth and innovation. The companies selected for inclusion have already generated revenue (which makes a small portion of the sector) and have an extensive backlog of orders, a mature prototype, and plans to start manufacturing dur...

12 Aug 2021  |  North America  |  Frost Radar

Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...

This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs),...

23 Dec 2022  |  North America  |  Market Research

Growth Opportunities in the Vendor Neutral Archiving Solutions Industry

Large Imaging Data Silos and a Rising Number of Medical Imaging Procedures Drive the Demand for VNA

Infographics

×

This research provides an overview of the global vendor neutral archive (VNA) solutions industry, covering North America (NA), Europe, and Asia-Pacific (APAC). VNA solutions are defined as software, platform, and professional services that healthcare facilities extensively utilize to establish a repository of images and data from different picture ...

The Advanced Manufacturing Technology Opportunity Engine focusses on innovations related to innovation in AI-based robotic solutions for industrial manufacturing, developments in multi-material and powder-bed fusion 3D printing, advanced robotic solution for welding applications. The Advanced Manufacturing TOE covers global innovations and developm...